- created_at
- provider_published_at
- 20260902T211500Z
- providers
- gdelt
- created_by
- scheduled-job:a5bbbe5ddcbdd49aeae94c04e3e1fefe5._scheduled_job.aed3f659-0656-4a52-a465-bd69571ddaa2
- source
- finanznachrichten.de
- themes
- world
- source_slug
- finanznachrichten-de
- provider_count
- 1
- url
- https://www.finanznachrichten.de/nachrichten-2026-09/69479272-inventiva-inventiva-announces-last-patient-visit-in-nativ3-phase-3-clinical-trial-of-lanifibranor-in-mash-399.htm
- country
- Germany
- language
- English
- org_id
- 0ac7c1ae-d6eb-4868-9eb4-96b085d4f7ba
- dedup_key
- 28e0b1f3b877adb15dfa293604cb17bb66a2c8004d2d0e921191135c3936939d
- last_modified_at
- provider
- gdelt
- feed_section
- World
- last_modified_by
- scheduled-job:a5bbbe5ddcbdd49aeae94c04e3e1fefe5._scheduled_job.aed3f659-0656-4a52-a465-bd69571ddaa2
- published_at
